Comparison of contract appearance of gadobenate-dimeglumine and GA-DTPA in intra-axial brain tumors;Vergleich des kontrastverhaltens von gadobenat-dimeglumine und gd-dtpa bei intraaxialen hirntumore. Eine doppelblinde randomisierte intraindividuelle cross-over-studie

Radiologe

Volumn 41, Issue 12, 2001, Pages 1063-1071

  Essig, M ^a   Hartmann, M ^b   Lodemann, K P ^c   Jansen, O ^b   Seeberg, A ^c   Runge, V M ^d   Knopp, M V ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c ALTANA PHARMA AG   (Germany)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Brain tumor; Contrast media; Gadobenat dimeglumine; Gd DTPA; Intra individual comparison

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN METASTASIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; GLIOMA; HUMAN; LUNG CARCINOMA; MALE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE DIAGNOSIS; RANDOMIZED CONTROLLED TRIAL;

BRAIN; BRAIN NEOPLASMS; CONTRAST MEDIA; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; GADOLINIUM DTPA; GLIOMA; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MEGLUMINE; OBSERVER VARIATION; ORGANOMETALLIC COMPOUNDS;

EID: 0035207204     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001170170006     Document Type: Article

References (26)

1. Magnetic resonance imaging of the brain: The optimal screening technique
2. Imaging of gliomas
3. Brain tumor, part 2
4. Glioblastoma multiforme and anaplastic astrocytoma: Pathologic criteria and prognostic implications
5. Bildgebung in der Diagnostik zerebraler Gliome und Metastasen
6. The use of MR contrast in neoplastic disease of the brain
7. Brain lesion contrast in MR imaging: Dependence on field strength and concentration of gadodiamide injection in patients and phantoms
8. High dose gadoteridol in MR imaging of intracranial neoplasms
9. MR evaluation of CNS tumors: Dose comparison study with gadopentetate dimeglumine and gadoteridol
10. Off-site evaluation of liver lesion detection by Gadobenat-Dimeglumine-enhanced MR imaging
11. Focal liver lesions: Evaluation of the efficacy of gadobenate dimeglumine in MR imaging - A multicenter phase III clinical study
12. Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging
13. A clinical comparison of the safety and efficacy of MultiHance (gadobenate dimeglumine) and Omniscan (Gadodiamide) in magnetic resonance imaging in patients with central nervous system pathology
14. Contrast dosage in the neuroimaging of brain tumors
15. Experience with high dose gadolinium MR imaging in the evaluation of brain metastases
16. Surgical decision making for malignant brain tumors
17. Verbesserter tumorkontrast und tumorabgrenzung in der stereotaktischen strahlentherapieplanung zerebraler gllome und metastasen mit kontrastmittel-unterstützter "fluid attenuated inversion recovery" bildgebung
18. Human cerebral gliomas: Correlation of postmortem MR findings and neuropathologic findings
19. Dose of contrast material in the MR imaging evaluation of central nervous system tumors
20. Comparison of single- and triple-dose contrast material in the MR screening of brain metastases
21. Resection for solitary brain metastasis. Role of adjuvant radiation and prognostic variables in 229 patients
22. Intracranial metastases from systemic cancer
23. Brain metastases
24. Diagnostic accuracy of MRI compared to CCT in patients with brain metastases
25. Long-term follow-up for brain metastases treated by percutaneous stereotactic single high-dose irradiation
26. Radiotherapy for brain metastases